Botox Maker Allergan Plc
- All
- News
-
Pfizer to Buy Allergan in Record $160 Billion Deal
Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a record-breaking deal worth $160 billion (Rs 10.56 lakh crore at $1 = Rs 66) to cut its US tax bill by moving its headquarters to Ireland.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
-
Pfizer to Buy Allergan in Record $160 Billion Deal
Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a record-breaking deal worth $160 billion (Rs 10.56 lakh crore at $1 = Rs 66) to cut its US tax bill by moving its headquarters to Ireland.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
